TORNTPHARM₹4,925.00

Torrent Pharmaceuticals Ltd.

· Pharma & Health
₹ CrorePeersSUNPHARMAJBCHEPHARMMANKINDZYDUSLIFEDIVISLABMAXHEALTHDRREDDYCIPLAMcap ₹1.67L Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment3,297.03,455.04,909.04,909.0
+ Capital Work-in-Progress281.0367.0457.0457.0
+ Investment Property—0.013.013.0
+ Goodwill338.0339.03,990.03,990.0
+ Other Intangibles4,503.04,152.024,280.024,280.0
+ Intangibles under Development80.0111.0184.0184.0
+ Non-current Investments32.044.083.083.0
+ Long-term Loans3.03.03.03.0
+ Other Non-current Financial Assets37.033.044.044.0
Non-current Financial Assets72.080.0130.0130.0
+ Deferred Tax Assets555.0595.0698.0698.0
+ Other Non-current Assets324.0268.0258.0258.0
Total Non-current Assets9,450.09,367.034,919.034,919.0
Current Assets
+ Inventories2,279.02,541.03,138.03,138.0
+ Current Investments141.0112.0866.0866.0
+ Trade Receivables1,844.01,867.03,031.03,031.0
+ Cash & Cash Equivalents835.0573.01,117.01,117.0
+ Other Bank Balances4.06.048.048.0
+ Short-term Loans3.05.05.05.0
+ Other Current Financial Assets201.0183.0558.0558.0
Current Financial Assets3,028.02,746.05,625.05,625.0
+ Other Current Assets304.0336.0629.0629.0
Total Current Assets5,611.05,623.09,392.09,392.0
Total Assets15,061.014,990.044,312.044,312.0
Equity
+ Equity Share Capital169.0169.0169.0169.0
+ Other Equity / Reserves6,687.07,422.08,220.08,220.0
Equity — Owners of Parent6,856.07,591.08,389.08,389.0
+ Minority Interest—0.09,196.09,196.0
Total Equity6,856.07,591.017,585.017,585.0
Liabilities
+ Borrowings — Non-current1,604.01,192.011,651.011,651.0
+ Other Non-current Financial Liab73.0160.0276.0276.0
Non-current Financial Liabilities1,677.01,352.011,927.011,927.0
+ Provisions — Non-current445.0501.0765.0765.0
+ Deferred Tax Liabilities656.0829.05,670.05,670.0
+ Other Non-current Liabilities1.00.022.022.0
Non-current Liabilities2,779.02,682.018,384.018,384.0
+ Borrowings — Current2,334.01,834.03,147.03,147.0
+ Trade Payables2,089.01,820.02,358.02,358.0
+ Other Current Financial Liab305.0423.02,042.02,042.0
Current Financial Liabilities4,728.04,077.07,547.07,547.0
+ Provisions — Current400.0408.0499.0499.0
+ Current Tax Liabilities168.096.0121.0121.0
+ Other Current Liabilities130.0136.0176.0176.0
Current Liabilities5,426.04,717.08,343.08,343.0
Total Liabilities8,205.07,399.026,727.026,727.0
Total Equity & Liabilities15,061.014,990.044,312.044,312.0
Assets — additional as-filed lines
+ Non-current Assets Held for Sale—0.01.01.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current—23.0163.0163.0
+ Dues to Other Creditors — Current—1,797.02,195.02,195.0
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.